Lv1
40 积分 2021-09-27 加入
Sintilimab Plus Modified FOLFIRINOX in Metastatic or Recurrent Pancreatic Cancer: The Randomized Phase II CISPD3 Trial
4个月前
已完结
The efficacy and safety profile of third-line treatment in patients with metastatic pancreatic adenocarcinoma
6个月前
已关闭
Entrectinib in patients with advanced or metastatic NTRK fusion-positive solid tumours: integrated analysis of three phase 1–2 trials
1年前
已完结
Fruquintinib plus paclitaxel versus placebo plus paclitaxel for gastric or gastroesophageal junction adenocarcinoma: the randomized phase 3 FRUTIGA trial
1年前
已完结
Fruquintinib plus paclitaxel versus paclitaxel as second-line therapy for patients with advanced gastric or gastroesophageal junction adenocarcinoma (FRUTIGA): A randomized, multicenter, double-blind, placebo-controlled, phase 3 study
1年前
已完结
Second-line treatment for metastatic pancreatic cancer
1年前
已完结
Safety, pharmacokinetics, and antitumour activity of trastuzumab deruxtecan (DS-8201), a HER2-targeting antibody–drug conjugate, in patients with advanced breast and gastric or gastro-oesophageal tumours: a phase 1 dose-escalation study
1年前
已关闭
Controlled backfill in oncology dose-finding trials
1年前
已完结
Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer
1年前
已完结
Maintenance Energy Requirements, Energy Retention and Heat Production of Young Obese (ob/ob) and Lean Mice Fed a High-Fat or a High-Carbohydrate Diet
3年前
已完结
皖公网安备34019202002308
